What’s New in Ontosight® Terminal 1.1 A Complete Guide toRead More
Category: news 2018
To unlock innovation, pharma needs to be honest about failure
Many successful leaders agree that a company’s willingness to embrace and learn from failure can unlock innovation – and it’s a lesson the pharmaceutical industry would do well to learn. Take Jeff Bezos, for example. As the CEO of Amazon, he encourages designing bold experiments that may lead to failure. After Amazon acquired Whole Foods, …
To unlock innovation, pharma needs to be honest about failure Read More »
How AI and blockchain can reduce corruption in Big Pharma
Gunjan Bhardwaj gives his opinion on how new technologies can help solve some of the problems in the pharma industry. The pharmaceutical industry today finds itself under a harsh spotlight as corruption accusations become increasingly prevalent. Though the vast majority of individual researchers, physicians, and other stakeholders involved in drug development have patients’ best interests …
How AI and blockchain can reduce corruption in Big Pharma Read More »
AI and Blockchain Platform Set to Revolutionize Drug Discovery
With the burgeoning advancement and adoption of advanced technologies such as artificial intelligence in various fields, there’s hope for a better future. These technologies are proving to be quite useful in solving various inefficiencies, particularly in the pharmaceutical sector. For instance, Innoplexus AG is one of the companies that are spearheading innovation in that field. …
AI and Blockchain Platform Set to Revolutionize Drug Discovery Read More »
Is Open Data the Silver Bullet for Better Drugs?
Open data sharing within the pharmaceutical industry is crucial for opening the floodgates of innovation. Successful innovation depends on having a rich supply of high-quality data because, without the right kind and quantity of data, there wouldn’t be a foundation for the research required to innovate. The best way to achieve this critical mass of …
Is Open Data the Silver Bullet for Better Drugs? Read More »
How Blockchain leverages the Power of Failure in Drug Development for the benefit of the patient
2.5 quintillion bytes of data are created every day. The challenge is to identify the relevant ones for solving a challenging question. That is where Artificial Intelligence solutions and blockchain can help make this knowledge public. If a beloved family member or close friend becomes seriously ill, you want the best treatment and cure for …
Innoplexus supports the European Summer School in Logic, Language and Information
In late 90s, internet solved the problem of data access. Then came the explosion of data with the web search and social media. Necessity to find relevant data & analyse it in specific context gave birth to the new field of science, the data sciences. The inter-disciplinary fields spans software development, data persistence & warehousing, …
Innoplexus supports the European Summer School in Logic, Language and Information Read More »
Why Amazon Needs AI At The Center Of Its Healthcare Strategy Forbes Technology Council
Post Written ByGunjan Bhardwaj Dr. Gunjan Bhardwaj is Co-Founder and Chief Executive of Innoplexus AG. In December 2017, Amazon, JPMorgan Chase and Berkshire Hathaway announced the formation of a new healthcare company which would use technology to provide high-quality healthcare to patients and families more simply, and at a more reasonable cost. This move and rumors …
Why Amazon Needs AI At The Center Of Its Healthcare Strategy Forbes Technology Council Read More »
Five use cases for blockchain in pharma Pharmaphorum
As blockchain expands its reach across different industries, Gunjan Bhardwaj examines some of its practical applications in the pharma industry. Blockchain is quickly increasing in interest and has received praise for its far-reaching applications, mainly because of its recent expansion into industries ranging from financial services to energy suppliers and pharmaceutical companies. It is a …
Five use cases for blockchain in pharma Pharmaphorum Read More »
Drug Prices Are Too Expensive: Here’s How Technology Can Fix That Forbes Technology Council
Post Written ByGunjan Bhardwaj Dr. Gunjan Bhardwaj is Co-Founder and Chief Executive of Innoplexus AG. The cost of drug development has skyrocketed, but disruptive technologies can bring it back down to earth. Over the past several decades, drug-development costs have risen significantly, from $250 million per approved drug prior to the 1990s to $403 million …